Medi Caps Ltd

Medi-caps Management Change

Medi-Caps Limited has re-appointed Alok K Garg as Executive Director and appointed Saloni Garg as an additional Executive Director for a 36-month term.

Medi Caps Annual General Meeting

Medi-Caps Limited held its 43rd Annual General Meeting on September 22, 2026. The meeting proceedings covered financial adoption and director appointments.

Medi Caps Other Announcement

Medi-Caps Limited is notifying shareholders without registered email addresses about the 43rd AGM and Annual Report availability. The documents are accessible via the provided web links.

Medi Caps Annual Report

Medi-Caps Limited has submitted its Integrated Annual Report for the financial year 2025-26. The 43rd Annual General Meeting is scheduled for September 22, 2026.

Medi Caps Annual General Meeting

Medi-Caps Limited has issued the notice for its 43rd Annual General Meeting scheduled for September 22, 2026. The meeting will address financial statements and director re-appointments.

Medi Caps Management Change

Medi-Caps Limited announced the resignations of its CFO and Chairperson, and appointed Akshit Garg as the new Chief Financial Officer.

Medi Caps Q1 FY27 Results: Net Loss of ₹2.2 Cr, Loss Narrows

Medi Caps Ltd reported revenue from operations of ₹2.8 Cr (+3.7% YoY) and a net loss of ₹2.2 Cr for Q1 FY27.

Key figure

Net loss ₹2.2 Cr

Medi Caps Management Change

Mr. Ramesh Chandra Mittal and Mrs. Kusum Mittal have resigned as Directors of Medi Caps Ltd effective August 6, 2026, citing personal health concerns.

Medi Caps Board Meeting Date

Medi Caps Ltd scheduled a Board Meeting for August 6, 2026. The board will consider the un-audited financial results for the quarter ended June 30, 2026.

Medi Caps Management Change

Medi-Caps Limited announced the resignation of Chief Financial Officer Hemant Sethi, effective June 6, 2026. The departure follows his decision to pursue external professional opportunities.

Medi Caps Other Announcement

Medi-Caps Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms adherence to SEBI regulations and listing requirements.

Medi Caps Management Change

Medi-Caps Limited re-appointed Praveen Shrivastava & Company as Internal Auditor for FY 2026-27. The move ensures continued statutory compliance and strengthens internal audit controls.

Execution

Financial year 2026-27

Medi Caps Q4 FY26 Results: Net Profit ₹3 Cr, Up 76.5% YoY

Medi Caps Ltd reported revenue from operations of ₹3.4 Cr (-51.4% YoY) and net profit of ₹3 Cr (+76.5% YoY) for Q4 FY26.

Key figure

Net profit ₹3 Cr · +76.5% YoY

Medi Caps Financial Results

Medi-Caps Limited reported its audited FY26 financial results, showing a standalone loss of ₹13.87 Lacs. Auditors issued an unmodified opinion for the consolidated and standalone accounts.

Medi Caps Board Meeting Date

Medi-Caps Limited scheduled a board meeting on May 21, 2026, to approve audited financial results. The trading window remains closed for designated insiders until results declaration.

Medi Caps Other Announcement

Medi-Caps Limited has issued an intimation to shareholders holding shares in physical mode to mandatorily furnish PAN, KYC, and bank account details. This compliance measure follows SEBI regulations to ensure seamless communication and direct dividend credits. Shareholders are required to update their records with the company's Registrar and Share Transfer Agent, Ankit Consultancy Pvt. Ltd.

Medi Caps Debt & Borrowing

Medi-Caps Ltd has informed the exchange that it does not qualify as a Large Corporate for the financial year 2026-27 under the SEBI framework. The company reported zero outstanding borrowings as of March 31, 2026, and confirmed that the requirement for mandatory borrowing through debt securities is not applicable.

Medi Caps Other Announcement

Medi-Caps Ltd has submitted the compliance certificate under Regulation 74(5) of SEBI (DP) Regulations for the quarter ended March 31, 2026. Confirmed by Ankit Consultancy, the filing verifies that share certificates received for dematerialisation were mutilated, cancelled, and substituted with the depository's name within 15 days.